Letter to the editor: Helicobacter pylori eradication - the proof is not in the symptoms
- PMID: 36379692
- DOI: 10.1136/gutjnl-2022-329057
Letter to the editor: Helicobacter pylori eradication - the proof is not in the symptoms
Keywords: 13C-UREA BREATH TEST; DYSPEPSIA; HELICOBACTER PYLORI; HELICOBACTER PYLORI - ASSESSMENT.
Conflict of interest statement
Competing interests: JB: Consultancy funding from Mayoly Spindler laboratories. MP: Consultancy funding from Ipsen, Advanced Accelerator Applications, INFAI and Mayoly Spindler laboratories and research funding to investigate the role of netazepide in gastric NETs from Trio Medicines. PM: Speaker fees, advisory board member and consultancy for Bayer, Biohit, Biocodex, Danone, Mayoly, Malesci, Menarini and Phathom Pharamaceuticals.
Comment on
-
British Society of Gastroenterology guidelines on the management of functional dyspepsia.Gut. 2022 Sep;71(9):1697-1723. doi: 10.1136/gutjnl-2022-327737. Epub 2022 Jul 7. Gut. 2022. PMID: 35798375 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical